Nemaura Medical (NMRD) Competitors $0.0002 0.00 (0.00%) As of 03/31/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSustainabilityTrendsBuy This Stock NMRD vs. VRAYQ, AHPI, VIVE, BRSH, UTRS, MOTS, DRTSW, ANZUW, IONM, and ATAKWShould you be buying Nemaura Medical stock or one of its competitors? The main competitors of Nemaura Medical include ViewRay (VRAYQ), Allied Healthcare Products (AHPI), Viveve Medical (VIVE), Bruush Oral Care (BRSH), Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Assure (IONM), and Aurora Technology Acquisition (ATAKW). These companies are all part of the "medical equipment" industry. Nemaura Medical vs. ViewRay Allied Healthcare Products Viveve Medical Bruush Oral Care Minerva Surgical Motus GI Alpha Tau Medical Anzu Special Acquisition Corp I Assure Aurora Technology Acquisition ViewRay (NASDAQ:VRAYQ) and Nemaura Medical (NASDAQ:NMRD) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, community ranking, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations. Which has preferable earnings and valuation, VRAYQ or NMRD? Nemaura Medical has lower revenue, but higher earnings than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViewRay$102.21M0.00-$107.33MN/AN/ANemaura Medical$3.02K2.67-$14.14M-$0.390.00 Does the media favor VRAYQ or NMRD? In the previous week, ViewRay's average media sentiment score of 0.00 equaled Nemaura Medical'saverage media sentiment score. Company Overall Sentiment ViewRay Neutral Nemaura Medical Neutral Is VRAYQ or NMRD more profitable? Company Net Margins Return on Equity Return on Assets ViewRayN/A N/A N/A Nemaura Medical N/A N/A N/A Does the MarketBeat Community believe in VRAYQ or NMRD? Nemaura Medical received 4 more outperform votes than ViewRay when rated by MarketBeat users. CompanyUnderperformOutperformViewRayN/AN/ANemaura MedicalOutperform Votes457.14% Underperform Votes342.86% Do institutionals & insiders have more ownership in VRAYQ or NMRD? 15.5% of ViewRay shares are owned by institutional investors. Comparatively, 4.4% of Nemaura Medical shares are owned by institutional investors. 2.5% of ViewRay shares are owned by insiders. Comparatively, 40.4% of Nemaura Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, VRAYQ or NMRD? ViewRay has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Comparatively, Nemaura Medical has a beta of 0.76, meaning that its share price is 24% less volatile than the S&P 500. SummaryNemaura Medical beats ViewRay on 4 of the 7 factors compared between the two stocks. Remove Ads Get Nemaura Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NMRD vs. The Competition Export to ExcelMetricNemaura MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$8,000.00$4.32B$5.54B$7.80BDividend YieldN/A48.04%5.35%4.05%P/E Ratio0.0028.5223.4718.58Price / Sales2.6747.64368.6387.66Price / CashN/A51.0838.1634.64Price / Book0.005.996.624.07Net Income-$14.14M$67.09M$3.20B$246.93M7 Day PerformanceN/A-6.84%-6.28%-3.96%1 Month PerformanceN/A-6.39%-1.41%-6.91%1 Year PerformanceN/A11.02%7.28%-2.19% Nemaura Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NMRDNemaura MedicalN/A$0.00flatN/AN/A$8,000.00$3,017.000.0040VRAYQViewRayN/AN/AN/AN/A$18,000.00$102.21M0.00300Gap DownHigh Trading VolumeAHPIAllied Healthcare ProductsN/AN/AN/AN/A$16,000.00$27.05M0.00150Analyst ForecastGap UpVIVEViveve MedicalN/A$0.00flatN/A+0.0%$2,000.00$6.83M0.0070BRSHBruush Oral CareN/A$0.00flatN/AN/A$1,000.00$2.92M0.0011Positive NewsUTRSMinerva SurgicalN/AN/AN/AN/A$1,000.00$51.69M0.00160MOTSMotus GIN/AN/AN/AN/A$1,000.00$319,000.000.0030DRTSWAlpha Tau MedicalN/A$0.23-3.5%N/A-11.2%$0.00N/A0.0080Gap DownANZUWAnzu Special Acquisition Corp IN/A$0.03+3.6%N/A-69.0%$0.00N/A0.002Gap UpIONMAssureN/AN/AN/AN/A$0.00$149,000.000.00130ATAKWAurora Technology AcquisitionN/A$0.02+0.5%N/A-67.3%$0.00N/A0.00N/A Remove Ads Related Companies and Tools Related Companies VRAYQ Competitors AHPI Competitors VIVE Competitors BRSH Competitors UTRS Competitors MOTS Competitors DRTSW Competitors ANZUW Competitors IONM Competitors ATAKW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NMRD) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nemaura Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nemaura Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NMRD Stock Free NMRD Stock Alerts